BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 16635751)

  • 1. Genetic association of interleukin-1beta and receptor antagonist (IL-1Ra) gene polymorphism with allograft function in renal transplant patients.
    Manchanda PK; Bid HK; Kumar A; Mittal RD
    Transpl Immunol; 2006 Apr; 15(4):289-96. PubMed ID: 16635751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
    Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
    J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients.
    Singh R; Manchanda PK; Kesarwani P; Srivastava A; Mittal RD
    Clin Transplant; 2009; 23(4):490-8. PubMed ID: 19486347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative pain, morphine consumption, and genetic polymorphism of IL-1beta and IL-1 receptor antagonist.
    Bessler H; Shavit Y; Mayburd E; Smirnov G; Beilin B
    Neurosci Lett; 2006 Aug; 404(1-2):154-8. PubMed ID: 16777324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of interleukin-1Ra gene polymorphism in patients with bladder cancer: case control study from North India.
    Bid HK; Manchanda PK; Mittal RD
    Urology; 2006 May; 67(5):1099-104. PubMed ID: 16698387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients.
    Sadeghi M; Daniel V; Naujokat C; Schmidt J; Mehrabi A; Zeier M; Opelz G
    Clin Transplant; 2010; 24(3):415-23. PubMed ID: 19925477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor-dependent genetic factors on long-term renal graft function.
    Krajewska M; Kościelska-Kasprzak K; Weyde W; Drulis-Fajdasz D; Madziarska K; Mazanowska O; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):2978-80. PubMed ID: 19857655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic association of interleukin-4, interleukin-10, and transforming growth factor-beta gene polymorphism with allograft function in renal transplant patients.
    Amirzargar M; Yavangi M; Basiri A; Moghadam SH; Khosravi F; Solgi G; Gholiaf M; Khoshkho F; Dadaras F; Mahmmodi M; Ansaripour B; Amirzargar A; Nikbin B
    Transplant Proc; 2007 May; 39(4):954-7. PubMed ID: 17524861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine gene polymorphism in kidney transplantation--impact of TGF-beta 1, TNF-alpha and IL-6 on graft outcome.
    Nikolova PN; Ivanova MI; Mihailova SM; Myhailova AP; Baltadjieva DN; Simeonov PL; Paskalev EK; Naumova EJ
    Transpl Immunol; 2008 Feb; 18(4):344-8. PubMed ID: 18158121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis.
    Cantagrel A; Navaux F; Loubet-Lescoulié P; Nourhashemi F; Enault G; Abbal M; Constantin A; Laroche M; Mazières B
    Arthritis Rheum; 1999 Jun; 42(6):1093-100. PubMed ID: 10366101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals.
    Kilpinen S; Huhtala H; Hurme M
    Eur Cytokine Netw; 2002; 13(1):66-71. PubMed ID: 11956022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors.
    Pirri A; Contieri FC; Benvenutti R; Bicalho Mda G
    Transpl Immunol; 2009 Jan; 20(3):143-9. PubMed ID: 18926911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in Korean patients with adult-onset Still's disease.
    Youm JY; Woo JH; Kim TH; Bae SC; Yoo DH
    Scand J Rheumatol; 2007; 36(5):390-3. PubMed ID: 17963170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic analysis of interleukin-1 promoter and receptor antagonist tandem repeat polymorphisms among HLA-identical renal transplant recipient and donor pairs.
    Jin Y; Ruiz P
    Transplant Proc; 2008 Jun; 40(5):1329-32. PubMed ID: 18589098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
    Dincić E; Zivković M; Stanković A; Obradović D; Alavantić D; Kostić V; Raicević R
    J Neuroimmunol; 2006 Aug; 177(1-2):146-50. PubMed ID: 16769128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes.
    Cvetkovic JT; Wallberg-Jonsson S; Stegmayr B; Rantapaa-Dahlqvist S; Lefvert AK
    J Rheumatol; 2002 Feb; 29(2):212-9. PubMed ID: 11838837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
    Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
    Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis.
    Powell JJ; Fearon KC; Siriwardena AK; Ross JA
    Surgery; 2001 May; 129(5):633-40. PubMed ID: 11331456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.
    Vamvakopoulos J; Green C; Metcalfe S
    Eur J Immunol; 2002 Oct; 32(10):2988-96. PubMed ID: 12355453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the polymorphism of interleukin-1 gene and the susceptibility to essential hypertension].
    Li Y; Xu P; Zhang PA; Li XY; Huang CX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):491-3. PubMed ID: 15476179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.